180
Participants
Start Date
February 28, 2019
Primary Completion Date
February 22, 2023
Study Completion Date
February 22, 2023
Nintedanib
diagnosed IPF patients initiating treatment with nintedanib
"Gen. Hosp. of Chest Diseases Sotiria, Univ. Resp. Med.", Athens
Univ. Gen. Hosp. of Patras, Pátrai
General University Hospital of Larissa, Larissa
General Hospital of Kerkyra, Corfu
"A Pulmonology Clinic G.Papanikolaou Hospital Thessaloniki", Thessaloniki
"General Hospital of Thessaloniki G. Papanikolaou", Thessaloniki
University General Hospital of Evros, Alexandroupoli
University Hospital of Heraklion, University Pulmonology Cl, Heraklion
University General Hospital Attikon, Athens
Univ. Gen. Hosp. of Ioannina, Ioannina
Lead Sponsor
Boehringer Ingelheim
INDUSTRY